Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer-Reference-Cited by-同舟云学术

Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

Published:2001-09 Issue:9 Volume:12 Page:1247-1254
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

O’Shaughnessy J.A.,Blum J.,Moiseyenko V.,Jones S.E.,Miles D.,Bell D.,Rosso R.,Mauriac L.,Osterwalder B.,Burger H.-U.,Laws S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/9/1247/19479807/12-9-1247.pdf

Reference21 articles.

1. Breast cancer Epidemiology, risk factors, screening;Gairard;Rev Prat,1998

2. Cancer Statistics 1996 CA Cancer;Parker;J Clin,1996

3. Cancer incidence and mortality in the European Union Cancer registry data and estimates of national incidence for 1990;Black;Eur J Cancer,1997

4. Current management of metastatic breast cancer;Perez;Semin Oncol,1999

5. Patient preferences for oral vs intravenous palliative chemotherapy;Liu;J Clin Oncol,1997

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Novel Treatment Options in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer;JCO Oncology Practice;2024-08-21

2. Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome;2024-08-09

3. Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study;Acta Oncologica;2024-06-23

4. A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer;International Journal of Molecular Sciences;2024-03-17

5. Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy;Medical Oncology;2023-12-16